The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Background: Long-term use of macrolide antibiotics is effective to prevent exacerbations in chronic obstructive pulmonary disease (COPD). As risks and side effects of long-term intervention outweigh the benefits in the general COPD population, the optimal dose, duration of treatment, and target population are yet to be defined. Hospitalization for an acute exacerbation (AE) of COPD may offer a targeted risk group and an obvious risk period for studying macrolide interventions. Methods/design: Patients with COPD, hospitalized for an AE, who have a smoking history of > 10 pack-years and had &... Mehr ...

Verfasser: Vermeersch, Kristina
Gabrovska, Maria
Deslypere, Griet
Demedts, Ingel K.
Slabbynck, Hans
Aumann, Joseph
Ninane, Vincent
Verleden, Geert M.
Troosters, Thierry
Bogaerts, Kris
Brusselle, Guy G.
Janssens, Wim
Dokumenttyp: Artikel
Erscheinungsdatum: 2016
Verlag/Hrsg.: DOVE MEDICAL PRESS LTD
Schlagwörter: COPD / acute exacerbation / macrolide antibiotics / azithromycin / physical activity / RCT
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26529358
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/1942/21548